JP2008510126A5 - - Google Patents

Download PDF

Info

Publication number
JP2008510126A5
JP2008510126A5 JP2007506605A JP2007506605A JP2008510126A5 JP 2008510126 A5 JP2008510126 A5 JP 2008510126A5 JP 2007506605 A JP2007506605 A JP 2007506605A JP 2007506605 A JP2007506605 A JP 2007506605A JP 2008510126 A5 JP2008510126 A5 JP 2008510126A5
Authority
JP
Japan
Prior art keywords
polypeptide
rhoa
anln
detecting
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007506605A
Other languages
English (en)
Japanese (ja)
Other versions
JP4874234B2 (ja
JP2008510126A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2005/014887 external-priority patent/WO2006016697A1/en
Publication of JP2008510126A publication Critical patent/JP2008510126A/ja
Publication of JP2008510126A5 publication Critical patent/JP2008510126A5/ja
Application granted granted Critical
Publication of JP4874234B2 publication Critical patent/JP4874234B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007506605A 2004-08-10 2005-08-09 非小細胞肺癌関連遺伝子ＡＮＬＮ、およびそのＲｈｏＡとの相互作用 Expired - Fee Related JP4874234B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60056104P 2004-08-10 2004-08-10
US60/600,561 2004-08-10
PCT/JP2005/014887 WO2006016697A1 (en) 2004-08-10 2005-08-09 Non-small cell lung cancer-related gene, anln, and its interactions with rhoa

Publications (3)

Publication Number Publication Date
JP2008510126A JP2008510126A (ja) 2008-04-03
JP2008510126A5 true JP2008510126A5 (https=) 2008-09-25
JP4874234B2 JP4874234B2 (ja) 2012-02-15

Family

ID=35355888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506605A Expired - Fee Related JP4874234B2 (ja) 2004-08-10 2005-08-09 非小細胞肺癌関連遺伝子ＡＮＬＮ、およびそのＲｈｏＡとの相互作用

Country Status (6)

Country Link
US (1) US20090297500A1 (https=)
EP (1) EP1787122B1 (https=)
JP (1) JP4874234B2 (https=)
AT (1) ATE483979T1 (https=)
DE (1) DE602005024021D1 (https=)
WO (1) WO2006016697A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8131476B2 (en) 2006-08-07 2012-03-06 General Electric Company System and method for co-registering multi-channel images of a tissue micro array
US8060348B2 (en) 2006-08-07 2011-11-15 General Electric Company Systems for analyzing tissue samples
WO2008063413A2 (en) 2006-11-13 2008-05-29 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of lung cancer
JP2010523081A (ja) * 2007-03-30 2010-07-15 オンコセラピー・サイエンス株式会社 Ｃｄｃａ８−ａｕｒｋｂ複合体を標的とするスクリーニング方法およびｎｓｃｌｃの治療方法
EP2161577A1 (en) * 2008-09-01 2010-03-10 Atlas Antibodies AB ANLN protein
WO2012006632A2 (en) 2010-07-09 2012-01-12 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
US9125899B1 (en) 2010-06-17 2015-09-08 Stc.Unm Modulators of GTPases and their use
EP3812469A1 (en) 2010-07-07 2021-04-28 Myriad Genetics, Inc. Gene signatures for cancer prognosis
US9605319B2 (en) 2010-08-30 2017-03-28 Myriad Genetics, Inc. Gene signatures for cancer diagnosis and prognosis
JP6127972B2 (ja) 2011-09-09 2017-05-17 コニカミノルタ株式会社 組織染色方法
CA3064363C (en) * 2011-10-24 2022-05-17 Somalogic, Inc. Non-small cell lung cancer biomarkers and uses thereof
JP5806168B2 (ja) * 2012-06-19 2015-11-10 国立大学法人 岡山大学 抗浸潤薬の新規スクリーニング法
WO2014078700A1 (en) 2012-11-16 2014-05-22 Myriad Genetics, Inc. Gene signatures for cancer prognosis
EP3143160B1 (en) 2014-05-13 2019-11-06 Myriad Genetics, Inc. Gene signatures for cancer prognosis
US10870854B2 (en) 2016-06-09 2020-12-22 The Board Of Regents Of The University Of Texas System Inhibitory RNA-based therapeutics targeting ANLN for cancer treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
EP1620573A4 (en) * 2003-04-15 2006-12-20 Avalon Pharmaceuticals DETERMINATION OF CANCER-ASSOCIATED GENES AND THERAPEUTIC OBJECTS USING MOLECULAR CYTOGENETIC PROCEDURES

Similar Documents

Publication Publication Date Title
JP2008510126A5 (https=)
US10041126B2 (en) Monocyte biomarkers for cancer detection
JP2009540803A5 (https=)
Daigo et al. From cancer genomics to thoracic oncology: discovery of new biomarkers and therapeutic targets for lung and esophageal carcinoma
JP2009519002A5 (https=)
JP2018536700A (ja) Ｐａｒｐ阻害剤を用いる小細胞肺がんの治療
WO2008132155A2 (en) Inhibitors of the binding between hdm2 and the proteasome
JP2012512389A5 (https=)
CN109337909B (zh) 一种检测肝癌耐药细胞株的核酸适体及其应用
US12325880B2 (en) Identification of PDE3 modulator responsive cancers
JP2008502332A5 (https=)
JP2007526759A5 (https=)
Lan et al. Significance of the detection of TIM-3 and FOXJ1 in prostate cancer
Hui Human hepatocellular carcinoma: expression profiles-based molecular interpretations and clinical applications
CN106676183A (zh) Zfhx4作为食管癌预后诊断的生物标志物
Shukla et al. Unbiased peptoid cell screen identifies a peptoid targeting newly appeared cell surface vimentin on tumor transformed early lung cancer cells
CN104039328B (zh) 对蛋白酶体抑制剂的反应的生物标记
CN105203763B (zh) 一种口腔癌特异性检测的试剂盒
JP2007523640A5 (https=)
CN112162097A (zh) Gdf1作为评估pd-1单抗治疗效果的生物标志物
Midorikawa et al. Molecular targets for liver cancer therapy: From screening of target genes to clinical trials
CN111944821A (zh) 一种结肠癌核酸适体的组织样本快速筛选及其在检测制剂中的应用
Olivier et al. Prognostic and predictive value of TP53 mutations in human cancer
AU2008357875A1 (en) Interferon Epsilon (IFNE1) as a marker for targeted cancer therapy
CN114231625A (zh) Qser1基因的用途及其相关药物